Continued ALS Research Supported by WCCT Global Following FDA Decision
Patients and advocacy groups for ALS research are petitioning Capitol Hill today following a decision handed down by the FDA which denied approval of new treatment for amyotrophic lateral sclerosis. WCCT supported recent clinical trials conducted for this experimental treatment. As a contract research organization, we must respect and defer to the due process for review of clinical trials by the FDA. Our hearts go out to all patients diagnosed with ALS, and WCCT Global will continue to support and expedite ALS research however possible with the study sponsor and appropriate regulatory agencies.